PD1 monoclonal antibody (Humanized) |
|
AP6666 |
Bioworld Biotech |
50ul |
EUR 158 |
|
|
|
Description: Human |
Human Antibody Laboratories manufactures the is bimekizumab a humanized monoclonal antibody? reagents distributed by Genprice. The Is Bimekizumab A Humanized Monoclonal Antibody? reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact human Antibody. Other Is products are available in stock. Specificity: Is Category: Bimekizumab Group: A Humanized
Bimekizumab ELISA Kit |
|
Abbexa |
100 µg |
EUR 812.5 |
Humanized Anti-EEEV Monoclonal antibody, clone 249 |
|
Creative Diagnostics |
250 µg, 1 mg |
Ask for price |
|
|
|
Description: Humanized |
A Humanized information
Humanized Anti-EEEV Monoclonal antibody, clone 249 |
|
CABT-CS919 |
Creative Diagnostics |
250 µg, 1 mg |
Ask for price |
|
|
|
Description: Humanized |
Humanized Anti-EEEV E2 Monoclonal antibody, clone 230 |
|
CABT-CS918 |
Creative Diagnostics |
250 µg, 1 mg |
Ask for price |
|
|
|
Description: Humanized |
Humanized Monoclonal (humanized/xolair biosimilar) Anti-Human IgE, aff pure |
|
10164-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Humanized IgG Monoclonal Antibody against SARS-CoV-2 S1 |
|
MBS398130-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
SARS-COV/SARS-COV-2 NP ScFv Humanized Monoclonal Antibody(2019-nCoV) |
|
MBS2563842-1mg |
MyBiosource |
1mg |
EUR 1050 |
SARS-COV/SARS-COV-2 NP ScFv Humanized Monoclonal Antibody(2019-nCoV) |
|
MBS2563842-5x1mg |
MyBiosource |
5x1mg |
EUR 4690 |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence |
|
TA813014 |
Origene Technologies GmbH |
100 µl |
Ask for price |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence |
|
TA813014S |
Origene Technologies GmbH |
30 µl |
Ask for price |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence |
|
TA813015 |
Origene Technologies GmbH |
100 µl |
Ask for price |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence |
|
TA813015S |
Origene Technologies GmbH |
30 µl |
Ask for price |
Humanized Monoclonal Antibody against SARS-CoV-2 Spike Protein-1 Receptor-binding Domain (S1 RBD) |
|
MBS398090-01mg |
MyBiosource |
0.1mg |
EUR 380 |
Humanized Monoclonal Antibody against SARS-CoV-2 Spike Protein-1 Receptor-binding Domain (S1 RBD) |
|
MBS398090-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1615 |
Humanized Monoclonal Antibody against SARS-CoV-2 Spike Protein-1 Receptor-binding Domain (S1 RBD) |
|
MBS398091-01mg |
MyBiosource |
0.1mg |
EUR 380 |
Humanized Monoclonal Antibody against SARS-CoV-2 Spike Protein-1 Receptor-binding Domain (S1 RBD) |
|
MBS398091-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1615 |
Carrier-free (BSA/glycerol-free) A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence |
|
CF813014 |
Origene Technologies GmbH |
100 µg |
Ask for price |
Carrier-free (BSA/glycerol-free) A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence |
|
CF813015 |
Origene Technologies GmbH |
100 µg |
Ask for price |
Humanized Monoclonal Anti-Human VEGF protein (Avastin/bevacizumab biosimilar) protein IgG1 (neutralizing) |
|
VEGF19-M |
Alpha Diagnostics |
50 ug |
EUR 578.4 |
